ESRRA and prostate cancer: In particular, some ONR members (including RORγ, TR2, TR4, COUP-TFII, ERRα, DAX-1 and SHP) exhibit multiple cross-talks with AR signaling in both normal and malignant prostatic cells, indicating their intricate interplay in prostate cancer progression [35].